Solara Active Pharma Sciences Limited (BOM:890202)
India flag India · Delayed Price · Currency is INR
308.70
+35.20 (12.87%)
At close: Apr 1, 2026

BOM:890202 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-74.15.4-5,674-221.8-581.5
Depreciation & Amortization
996.8974.81,0111,0661,081
Other Amortization
-17.721.946.141.9
Loss (Gain) From Sale of Assets
2.6-19.74.57.7
Asset Writedown & Restructuring Costs
-0.825.3--
Stock-Based Compensation
46.726.860.5-13.1
Provision & Write-off of Bad Debts
39.410.2109.956.688.2
Other Operating Activities
899.41,0623,662603.493.1
Change in Accounts Receivable
-1,113198.11,782-528-145.5
Change in Inventory
0.3418130.8173.2-2,806
Change in Accounts Payable
259-594.373389-238.8
Change in Other Net Operating Assets
472.28.4-79.2-26.852.2
Operating Cash Flow
1,5292,1281,0891,563-2,420
Operating Cash Flow Growth
-28.15%95.48%-30.32%--
Capital Expenditures
-528.2-399.4-410.6-1,113-2,086
Sale of Property, Plant & Equipment
5.13.810.4131.3
Divestitures
-9.6---
Investment in Securities
-486.2---12.8-
Other Investing Activities
2117.741.6125-343.6
Investing Cash Flow
-988.3-368.3-35.1-811.4-2,429
Short-Term Debt Issued
--1,115394.42,487
Long-Term Debt Issued
495750496832,624
Total Debt Issued
4957501,1641,0775,111
Short-Term Debt Repaid
-768.1-1,854---
Long-Term Debt Repaid
-925.2-1,131-1,194-1,331-962.2
Total Debt Repaid
-1,693-2,985-1,194-1,331-962.2
Net Debt Issued (Repaid)
-1,198-2,235-30.2-253.14,149
Issuance of Common Stock
1,5851,590--29
Common Dividends Paid
-----107.8
Other Financing Activities
-922.4-1,160-1,026-874.5-734
Financing Cash Flow
-535.5-1,805-1,057-1,1283,336
Net Cash Flow
5.3-44.9-2.9-376.5-1,513
Free Cash Flow
1,0011,729678.1449.4-4,507
Free Cash Flow Growth
-42.10%154.95%50.89%--
Free Cash Flow Margin
7.28%13.47%5.26%3.11%-35.53%
Free Cash Flow Per Share
22.6943.3317.7512.48-125.38
Cash Interest Paid
-1,1311,035-734
Cash Income Tax Paid
-9-9-135.4181
Levered Free Cash Flow
232.8595.652,768-82.46-5,069
Unlevered Free Cash Flow
824.991,2793,402460.04-4,616
Change in Working Capital
-381.730.21,9067.4-3,138
Source: S&P Global Market Intelligence. Standard template. Financial Sources.